Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60-75 Years: Protocol-Defined Safety Analysis After 100 Patients
- Publication date
- 1 January 2012
- Publisher
- 'American Society of Hematology'